Skip to main content
Premium Trial:

Request an Annual Quote

MilliporeSigma Licenses Sigma-Aldrich CRISPR IP to Agbio Firm BetterSeeds

NEW YORK — MilliporeSigma, through its Sigma-Aldrich business, has licensed its portfolio of CRISPR-related intellectual property to Israeli agbio firm BetterSeeds for use in plants.

According to MilliporeSigma, BetterSeeds will use the patented technology for trait improvement in cash crops such as cannabis and cowpea. Other terms of the deal, including financials, were not disclosed.

"CRISPR-based integration is a fundamental tool for many genome-editing applications but has historically been exceptionally difficult to do in plants," Nina Bauer, head of gene editing and novel modalities at MilliporeSigma, said in a statement. "With this collaboration, we aim to test the boundaries of the currently available technology in this critical sector helping to bring food security to millions whilst lowering the environmental impact of the farming process."

In mid-2019, Burlington, Massachusetts-based MilliporeSigma partnered with the Broad Institute to develop a framework for streamlining the way they offer nonexclusive licenses to their respective CRISPR IP.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.